D Béracochéa1, J N Philippin, S Meunier, P Morain, K Bernard. 1. Centre de Neurosciences Intégratives et Cognitives(CNIC), UMR CNRS 5228, Bat Biologie Animale, Univ. Bordeaux 1 et 2, 33405, Talence-cedex, France. d.beracochea@lnc.u-bordeaux1.fr
Abstract
INTRODUCTION: This study compared the effects of S 18986, a positive allosteric modulator of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)-type glutamate receptors, to those of donepezil a cholinesterase inhibitor on memory impairments induced by ageing in a contextual serial discrimination (CSD) task in middle-aged mice. MATERIALS AND METHODS: The CSD task involved the learning of two consecutive discriminations in a four-hole board, each performed on two different floors. This model has been developed to study simultaneously different forms of memory in mice (i.e., episodic-like vs semantic-like forms of memory). We showed that placebo-middle-aged mice (14-15 months old) and placebo-aged subjects (19-20 months old) exhibited a severe memory deficit for the first but not the second discrimination, which was due to an increase in interference, as compared with placebo-treated young mice (5 months old). Middle-aged mice were given (9 days) per os administration of either donepezil, S 18986, or placebo. RESULTS AND DISCUSSION: Both 0.3 mg/kg donepezil and 0.1 mg/kg S 18986 reversed the deficit of middle-aged mice through a significant increase in contextually correct responses and in parallel a tendency to reduce interfering responses. CONCLUSION: Overall, S 18986 emerges as having a beneficial impact on contextual memory processes in middle-aged mice.
INTRODUCTION: This study compared the effects of S 18986, a positive allosteric modulator of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)-type glutamate receptors, to those of donepezil a cholinesterase inhibitor on memory impairments induced by ageing in a contextual serial discrimination (CSD) task in middle-aged mice. MATERIALS AND METHODS: The CSD task involved the learning of two consecutive discriminations in a four-hole board, each performed on two different floors. This model has been developed to study simultaneously different forms of memory in mice (i.e., episodic-like vs semantic-like forms of memory). We showed that placebo-middle-aged mice (14-15 months old) and placebo-aged subjects (19-20 months old) exhibited a severe memory deficit for the first but not the second discrimination, which was due to an increase in interference, as compared with placebo-treated young mice (5 months old). Middle-aged mice were given (9 days) per os administration of either donepezil, S 18986, or placebo. RESULTS AND DISCUSSION: Both 0.3 mg/kg donepezil and 0.1 mg/kg S 18986 reversed the deficit of middle-aged mice through a significant increase in contextually correct responses and in parallel a tendency to reduce interfering responses. CONCLUSION: Overall, S 18986 emerges as having a beneficial impact on contextual memory processes in middle-aged mice.
Authors: Christopher S Rex; Enikö A Kramár; Laura L Colgin; Bin Lin; Christine M Gall; Gary Lynch Journal: J Neurosci Date: 2005-06-22 Impact factor: 6.167
Authors: Susanna Rosi; Maria Grazia Giovannini; Pierre J Lestage; Carmen Muñoz; Laura Della Corte; Giancarlo Pepeu Journal: Neurosci Lett Date: 2004-05-06 Impact factor: 3.046
Authors: S J Kelly; K Bernard; C Muñoz; R C Lawrence; J Thacker; C A Grillo; G G Piroli; L P Reagan Journal: Psychopharmacology (Berl) Date: 2008-09-02 Impact factor: 4.530
Authors: S Bretin; A Krazem; N Henkous; C Froger-Colleaux; E Mocaer; C Louis; N Perdaems; A Marighetto; D Beracochea Journal: Psychopharmacology (Berl) Date: 2017-11-22 Impact factor: 4.530
Authors: Bashkim Kadriu; Laura Musazzi; Jenessa N Johnston; Lisa E Kalynchuk; Hector J Caruncho; Maurizio Popoli; Carlos A Zarate Journal: Drug Discov Today Date: 2021-08-03 Impact factor: 8.369